- Home
- TSHA vs KIO Comparison
TSHA vs KIO Comparison
Compare TSHA & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- KIO
- Stock Information
- Founded
- TSHA 2019
- KIO 2011
- Country
- TSHA United States
- KIO United States
- Employees
- TSHA N/A
- KIO 2400
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- KIO Investment Managers
- Sector
- TSHA Health Care
- KIO Finance
- Exchange
- TSHA Nasdaq
- KIO Nasdaq
- Market Cap
- TSHA 403.7M
- KIO 404.1M
- IPO Year
- TSHA 2020
- KIO N/A
- Fundamental
- Price
- TSHA $2.00
- KIO $13.18
- Analyst Decision
- TSHA Strong Buy
- KIO
- Analyst Count
- TSHA 8
- KIO 0
- Target Price
- TSHA $6.63
- KIO N/A
- AVG Volume (30 Days)
- TSHA 5.4M
- KIO 136.5K
- Earning Date
- TSHA 11-13-2024
- KIO 01-01-0001
- Dividend Yield
- TSHA N/A
- KIO 10.82%
- EPS Growth
- TSHA N/A
- KIO N/A
- EPS
- TSHA N/A
- KIO N/A
- Revenue
- TSHA $9,915,000.00
- KIO N/A
- Revenue This Year
- TSHA N/A
- KIO N/A
- Revenue Next Year
- TSHA N/A
- KIO N/A
- P/E Ratio
- TSHA N/A
- KIO N/A
- Revenue Growth
- TSHA N/A
- KIO N/A
- 52 Week Low
- TSHA $1.19
- KIO $10.52
- 52 Week High
- TSHA $4.32
- KIO $13.59
- Technical
- Relative Strength Index (RSI)
- TSHA 41.45
- KIO 32.78
- Support Level
- TSHA $1.97
- KIO $13.56
- Resistance Level
- TSHA $2.72
- KIO $13.78
- Average True Range (ATR)
- TSHA 0.23
- KIO 0.12
- MACD
- TSHA -0.10
- KIO -0.01
- Stochastic Oscillator
- TSHA 2.24
- KIO 6.24
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.